Ashland Inc. logo

Ashland Inc. (ASH)

Market Closed
15 Oct, 08:00 PM
NYSE NYSE
$
71. 59
+0.27
+0.3786%
Pre Market
$
71. 59
0 0%
3.23B Market Cap
25.2 P/E Ratio
1.62% Div Yield
457,100 Volume
3.83 Eps
$ 71.32
Previous Close
Add Transaction
Day Range
70.8 71.97
Year Range
47.12 78.25
Want to track ASH and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Ashland Inc. (ASH) Analyst/Investor Day Transcript

Ashland Inc. (ASH) Analyst/Investor Day Transcript

Ashland Inc. (ASH) Analyst/Investor Day Transcript

Seekingalpha | 4 weeks ago
Here's Why You Should Retain ASH Stock in Your Portfolio Now

Here's Why You Should Retain ASH Stock in Your Portfolio Now

Ashland is using cost savings, portfolio optimization and buybacks to strengthen margins and free cash flow despite tariff and demand headwinds.

Zacks | 4 weeks ago
Ashland (ASH) Up 2% Since Last Earnings Report: Can It Continue?

Ashland (ASH) Up 2% Since Last Earnings Report: Can It Continue?

Ashland (ASH) reported earnings 30 days ago. What's next for the stock?

Zacks | 1 month ago
ASH Launches Permexa Sodium Caprate to Support Oral Biologics Growth

ASH Launches Permexa Sodium Caprate to Support Oral Biologics Growth

Ashland launches Permexa sodium caprate to support oral peptide and biologic development with enhanced processing and permeability.

Zacks | 1 month ago
Ashland Q3 Earnings Call Highlights

Ashland Q3 Earnings Call Highlights

Ashland NYSE: ASH reported higher sales across all four business units in its fiscal third quarter of 2026, supported by volume growth, pricing actions and demand in its Life Sciences and Personal Care operations. The company reaffirmed its full-year sales and adjusted EBITDA outlook, while lowering its adjusted earnings-per-share growth forecast because of a higher tax rate tied to unfavorable discrete items.

Marketbeat | 2 months ago
Ashland's Q3 Earnings Miss Estimates, Sales Beat on Volume Growth

Ashland's Q3 Earnings Miss Estimates, Sales Beat on Volume Growth

ASH's Q3 sales beat estimates as volume growth lifted all segments, but adjusted earnings missed and the company lowered its fiscal 2026 EPS growth outlook.

Zacks | 2 months ago
Ashland (ASH) Q3 Earnings Lag Estimates

Ashland (ASH) Q3 Earnings Lag Estimates

Ashland (ASH) came out with quarterly earnings of $1.02 per share, missing the Zacks Consensus Estimate of $1.03 per share. This compares to earnings of $1.04 per share a year ago.

Zacks | 2 months ago
Ashland (ASH) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates

Ashland (ASH) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates

Although the revenue and EPS for Ashland (ASH) give a sense of how its business performed in the quarter ended June 2026, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

Zacks | 2 months ago
Ashland (ASH) Expected to Beat Earnings Estimates: Can the Stock Move Higher?

Ashland (ASH) Expected to Beat Earnings Estimates: Can the Stock Move Higher?

Ashland (ASH) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Zacks | 2 months ago
Why Is Ashland (ASH) Up 16.6% Since Last Earnings Report?

Why Is Ashland (ASH) Up 16.6% Since Last Earnings Report?

Ashland (ASH) reported earnings 30 days ago. What's next for the stock?

Zacks | 4 months ago
ASH Q2 Earnings and Sales Miss on Weak Pricing, Intermediates Weakness

ASH Q2 Earnings and Sales Miss on Weak Pricing, Intermediates Weakness

ASH posts weaker Q2 results with earnings and sales missing estimates despite gains in Personal Care and steady Life Sciences demand.

Zacks | 5 months ago
Ashland Inc. (ASH) Q2 2026 Earnings Call Transcript

Ashland Inc. (ASH) Q2 2026 Earnings Call Transcript

Ashland Inc. (ASH) Q2 2026 Earnings Call Transcript

Seekingalpha | 5 months ago
Loading...
Load More